Skip to content
10-Q

Quarterly Report

AMEXDRUG CORP

0001096906-12-001982

← back to feed
Filed
Aug 10, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Aug 6, 2012 8.47M sh
Stockholders Equity Q2 2012 · Jun 30, 2012 $494.03K
Stockholders Equity Q2 2012 · Dec 31, 2011 $348.58K
Current Liabilities Q2 2012 · Jun 30, 2012 $898.6K
Current Liabilities Q2 2012 · Dec 31, 2011 $1.25M
Current Assets Q2 2012 · Jun 30, 2012 $1.3M
Current Assets Q2 2012 · Dec 31, 2011 $1.5M
Total Assets Q2 2012 · Jun 30, 2012 $1.39M
Total Assets Q2 2012 · Dec 31, 2011 $1.6M
Stock Repurchased Q2 2012 · Jun 30, 2011 $1.1K
Capex Q2 2012 · Jun 30, 2011 −$11.29K
Operating Cash Flow Q2 2012 · Jun 30, 2011 −$246.05K
Sga Expense Q2 2012 · Jun 30, 2011 $191.01K
Sga Expense Q2 2012 · Jun 30, 2011 $341.64K
Net Income restated Q2 2012 · Jun 30, 2011 $71.55K
Net Income Q2 2012 · Jun 30, 2011 $235.66K
Operating Income Q2 2012 · Jun 30, 2011 $129.16K
Operating Income Q2 2012 · Jun 30, 2011 $408.87K
Gross Profit Q2 2012 · Jun 30, 2011 $321.38K
Gross Profit Q2 2012 · Jun 30, 2011 $752.68K
Cost Of Revenue Q2 2012 · Jun 30, 2011 $3.3M
Cost Of Revenue Q2 2012 · Jun 30, 2011 $5.71M
Revenue Q2 2012 · Jun 30, 2011 $3.62M
Revenue Q2 2012 · Jun 30, 2011 $6.46M